Asia-pacific To Register The Fastest Growth In The Cancer/tumor Profiling Market

By Author: Pramod Kumar
Total Articles: 98
Comment this article

Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass. For effective treatment, merely detecting the tumor within the body is not enough; its nature and the exact mutation which caused it also need to be studied.
Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample
Therefore, owing to the increasing number of people suffering from this disease and the high focus on deeply studying its various aspects, in order to device an effective therapy, the cancer/tumor profiling market is growing around the world. Several technologies, including quantitative polymerase chain reaction (QPCR), next-generation sequencing (NGS), in-situ hybridization (ISH), ...
... immunohistochemistry (IHC), and microarray, are used to study the tumors. Of these, NGS has been the most widely preferred till now, on account of its ability to quickly detect the sequencing of the deoxyribonucleic acid (DNA) in the genome.
Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=cancer-profiling-market
This is concurrent with the fact that among the genomics, proteomics, metabolomics, and epigenetics techniques, genomics is the most widely used one. As the root cause of the cancer can be determined by studying which gene mutated and how, targeted therapies can be devised. Such analysis can also help ascertain if the patient would be at risk of a relapse. All these techniques and technologies find application in diagnostics, personalized medicine, prognostics, and biomarker discovery. Among these, they are most heavily utilized for personalized medicine, which becoming increasingly popular among cancer patients.

Pramod Kumar is a Digital Marketing Specialist at IG Transformation Partners, specializing in digital strategy, content marketing, and online brand positioning. He focuses on developing marketing initiatives that help organizations strengthen their digital presence and communicate their value effectively in competitive global markets. His expertise includes search engine optimization (SEO), LinkedIn marketing, B2B digital campaigns, market-driven content creation, and digital analytics. By combining strategic thinking with creative storytelling, he helps translate industry insights into compelling marketing content that engages audiences and supports business growth. At IG Transformation Partners, Pramod contributes to promoting thought leadership, digital transformation insights, and innovative solutions through targeted marketing strategies and data-driven digital campaigns.